Aehr Test Systems insider exercises options; holding 178,989 shares

Rhea-AI Filing Summary

Aehr Test Systems reported an insider transaction by its Exec VP of Sales & Marketing. On 10/22/2025, the officer exercised options and acquired 110,283 and 185 shares of common stock at an exercise price of $2.03 per share (transaction code M).

Following these transactions, the officer reported 178,989 shares beneficially owned, held directly. The exercised options were from grants dated 11/23/2018 with expiration on 10/23/2025, and the remaining derivative balance for these grants is 0. A footnote states the reported amount includes shares subject to unvested restricted stock units.

Insider Trade Summary

110,468 shares exercised/converted

Mixed 4 txns

Insider ROGERS VERNON

Role Exec VP of Sales & Mktg.

Type	Security	Shares	Price	Value
Exercise	Option (right to buy)	110,283	$0.00	--
Exercise	Non-Qualified Option (right to buy)	185	$0.00	--
Exercise	Common Stock	110,283	$2.03	$224K
Exercise	Common Stock	185	$2.03	$375.55

Holdings After Transaction: Option (right to buy) — 0 shares (Direct); Non-Qualified Option (right to buy) — 0 shares (Direct); Common Stock — 178,804 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROGERS VERNON

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CA 94539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec VP of Sales & Mktg.

3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/22/2025		M		110,283	A	$2.03	178,804	D
Common Stock	10/22/2025		M		185	A	$2.03	178,989(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$2.03	10/22/2025		M			110,283	11/23/2018	10/23/2025	Common Stock	110,283	$0	0	D
Non-Qualified Option (right to buy)	$2.03	10/22/2025		M			185	11/23/2018	10/23/2025	Common Stock	185	$0	0	D

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AEHR's insider report on Form 4?

An officer exercised options (code M) and acquired 110,283 and 185 AEHR common shares at $2.03 on 10/22/2025.

How many AEHR shares does the reporting person own after the transaction?

The officer reported 178,989 shares beneficially owned, held directly.

What was the option exercise price and dates involved?

The options were exercised at $2.03; the underlying grants were dated 11/23/2018 and expired on 10/23/2025.

Were any derivative securities remaining after the exercise?

No. The number of derivative securities remaining from these grants is reported as 0.

Does the reported ownership include unvested RSUs?

Yes. A footnote states the amount reported includes shares subject to unvested restricted stock units.

What is the insider’s role at AEHR?

The reporting person is an Officer, serving as Exec VP of Sales & Mktg.